Internal Medicine, Endocrinology, Diabetes, & Metabolism · Astoria, NY
NPI
1043256928
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3435 29th St
Astoria, NY, 11106
Phone (718) 274-0105
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
374 services
Medicare patients, 2024
151
Average age 72
Drug cost, 2024
$2.2M
6,662 prescriptions
Company payments, 2025
$173
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fauzia F Syed-Khan was code 99213 (office e&m - established), 280 times for 124 patients. In total Fauzia F Syed-Khan billed 374 services in 8 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-03-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 280 | 124 | $74.08 | $21K |
| 99203 Office E&M - New | Office | 56 | 56 | $87.86 | $4,920 |
| 99214 Office E&M - Established | Office | 14 | 12 | $93.26 | $1,306 |
By year: 2022 $28K for 367 services; 2023 $30K for 392 services; 2024 $29K for 374 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fauzia F Syed-Khan prescribed most often to Medicare patients was Levothyroxine Sodium, with 945 prescriptions and refills. In total Fauzia F Syed-Khan wrote 6,662 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 945 | 1,612 | 209 | $10K |
| Metformin Hcl Generic | 489 | 968 | 150 | $2,959 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 480 | 686 | 110 | $224K |
| Jardiance Empagliflozin | 325 | 471 | 71 | $262K |
| Trulicity Dulaglutide | 276 | 360 | 55 | $325K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 269 | 393 | 81 | $28K |
| Alcohol Prep Pads Alcohol Antiseptic Pads | 247 | 459 | 86 | $3,121 |
| Janumet Sitagliptin Phos/Metformin Hcl | 211 | 348 | 56 | $182K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 194 | 434 | 63 | $627 |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 193 | 430 | 73 | $17K |
| Glimepiride Generic | 192 | 274 | 43 | $1,298 |
| Ozempic Semaglutide | 188 | 217 | 36 | $191K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 173 | 426 | 81 | $16K |
| Novolog Flexpen Insulin Aspart | 156 | 268 | 43 | $34K |
| Synthroid Levothyroxine Sodium | 142 | 358 | 40 | $15K |
Brand drugs: 2,869 claims; generic drugs: 2,652 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fauzia F Syed-Khan $173 ($173 in general payments such as food, travel and fees) from 2 companies. The largest payer was Astellas Pharma US Inc with $152.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 3 | $152 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.